… against gram-positive and gram-negative pathogens, β-lactam … the epidemiology of isolates
producing β-lactamases is … of isolates carrying common β-lactamases against clinically …

… The aim of this study was to determine the prevalence of AMR in the clinical isolates of GNB
from adult, pediatric, and neonatal patients in these ICU at a tertiary-care hospital in Mexico. …

… (WHO) has listed development of new therapeutic agents for … leading causes of serious
Gram-negative infections such as … The prevalence of 3GC-resistant genotypes within the entire …

… evolution of new β-lactamases that hydrolysed these new drugs. … coli clinical isolates collected
as part of the SENTRY and … A recent study of Gram-negative blood culture isolates taken …

… Beta-lactamase (β-lactamase)-producing Gram-negative … β-lactamases (ESBLs) and AmpCs
among GNB from clinical sources… new treatment strategies in order to mitigate this problem. …

… bla genes among non-clinical isolates from food and wastewater … A high prevalence of ESBL
producing bacteria has been … [46,47], the inclusion of New Delhi metallo-beta-lactamase 1(…

… Extended-spectrum β-lactamases (ESBLs) are a predominant cause of β-lactam resistance
… study involving 322 clinical isolates of Gram negative bacilli that were collected from different …

… , β-lactamases are most important in Gram-negative bacteria, … β-lactamases or by acquisition
of foreign DNA encoding new … maltophilia clinical isolates from the United States revealed …

… of genes encoding clinically relevant β-lactamases—K. … clinical isolates of Enterobacterales
collected between 2016–2018 from USA and Europe: genotypic analysis of β-lactamases …

… Gram-negative isolates [7, 8], and the number of ESBL producers is growing exponentially
[9]. Many new … has resulted in the emergence of new variants of β-lactamases [10]. Hence, …